The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey
Open accessAbstract
BACKGROUND: Chronic kidney disease is an important risk factor for death and cardiovascular-related morbidity, but estimates to date of its prevalence in Canada have generally been extrapolated from the prevalence of end-stage renal disease. We used direct measures of kidney function collected from a nationally representative survey population to estimate the prevalence of chronic kidney disease among Canadian adults. METHODS: We examined data for 3689 adult participants of cycle 1 of the Canadian Health Measures Survey (2007-2009) for the presence of chronic kidney disease. We also calculated the age-standardized prevalence of cardiovascular risk factors by chronic kidney disease group. We cross-tabulated the estimated glomerular filtration rate (eGFR) with albuminuria status. RESULTS: The prevalence of chronic kidney disease during the period 2007-2009 was 12.5%, representing about 3 million Canadian adults. The estimated prevalence of stage 3-5 disease was 3.1% (0.73 million adults) and albuminuria 10.3% (2.4 million adults). The prevalence of diabetes, hypertension and hypertriglyceridemia were all significantly higher among adults with chronic kidney disease than among those without it. The prevalence of albuminuria was high, even among those whose eGFR was 90 mL/min per 1.73 m(2) or greater (10.1%) and those without diabetes or hypertension (9.3%). Awareness of kidney dysfunction among adults with stage 3-5 chronic kidney disease was low (12.0%). INTERPRETATION: The prevalence of kidney dysfunction was substantial in the survey population, including individuals without hypertension or diabetes, conditions most likely to prompt screening for kidney dysfunction. These findings highlight the potential for missed opportunities for early intervention and secondary prevention of chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Sontrop, J. M., Dixon, S. N., Garg, A. X., Buendia-Jimenez, I., Dohein, O., Huang, S.-H. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,871
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Levey, A. S., de Jong, P. E., Coresh, J., El Nahas, M., Astor, B. C., Matsushita, K., Gansevoort, R. T., Kasiske, B. L., & Eckardt, K.-U. (2011) · Kidney International · doi:10.1038/ki.2010.483 · Cited by 2,345
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241 · cited 1×
“The increasing prevalence of chronic kidney disease can be attributed in part to the growing elderly population and to increasing rates of diabetes and hypertension.(1,6,7) Albuminuria, which can result from abnormal vascular permeability, atherosclerosis or renal disease, has gained recognition as an independent risk…”
BackgroundBooth, G., & Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.010 · Cited by 1,220
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.39 · Cited by 1,041
Prevalence of chronic kidney disease in population-based studies: Systematic review
Zhang, Q.-L., & Rothenbacher, D. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-117 · Cited by 1,021
Matsushita, K., Mahmoodi, B. K., Woodward, M., Emberson, J. R., Jafar, T. H., Jee, S. H., Polkinghorne, K. R., Shankar, A., Smith, D. H., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.3954 · Cited by 988
Wen, C. P., Cheng, T. Y. D., Tsai, M. K., Chang, Y. C., Chan, H. T., Tsai, S. P., Chiang, P. H., Hsu, C. C., Sung, P. K., Hsu, Y. H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60952-6 · Cited by 920
Astor, B. C., the Chronic Kidney Disease Prognosis Consortium, Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., Jong, P. E. D., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.550 · Cited by 774
Genest, J., McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., Couture, P., Dufour, R., Fodor, G., Francis, G. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70715-9 · Cited by 768
Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.009 · Cited by 728
Guidelines for the management of chronic kidney disease
Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Burns, K., Manns, B., White, C., Madore, F., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080351 · Cited by 420
Self-citationGarg, A. X., Kiberd, B. A., Clark, W. F., Haynes, R. B., & Clase, C. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00356.x · Cited by 355
Canadian Health Measures Survey: rationale, background and overview.
Tremblay, M. S., Wolfson, M. C., & Gorber, S. C. (2007) · PubMed · Cited by 203
Prevalence of metabolic syndrome in the Canadian adult population
Riediger, N. D., & Clara, I. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110070 · Cited by 192
Folate status of the population in the Canadian Health Measures Survey
Colapinto, C. K., O'Connor, D. L., & Tremblay, M. S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.100568 · Cited by 175
Population based screening for chronic kidney disease: cost effectiveness study
Manns, B., Hemmelgarn, B., Tonelli, M., Au, F., Chiasson, T. C., Dong, J., Klarenbach, S., & on behalf of the Alberta Kidney Disease Network (2010) · BMJ · doi:10.1136/bmj.c5869 · Cited by 161
Canadian Health Measures Survey: sampling strategy overview.
Giroux, S. (2007) · PubMed · Cited by 131
The Role of Obesity and Its Bioclinical Correlates in the Progression of Chronic Kidney Disease
Chalmers, L. J., Kaskel, F. J., & Bamgbola, O. F. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.07.010 · Cited by 116
Foster, M. C., Hwang, S., Larson, M. G., Parikh, N. I., Meigs, J. B., Vasan, R. S., Wang, T. J., Levy, D. A., & Fox, C. S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1386 · Cited by 115
National Kidney Disease Education Program.
Hostetter, T. H., & Lising, M. (2002) · PubMed · Cited by 112
National Kidney Disease Education Program
Hostetter, T. H., & Lising, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070156.78824.c7 · Cited by 106
Canadian Health Measures Survey: clinic operations and logistics.
Bryan, S. N., St-Denis, M., & Wojtas, D. (2007) · PubMed · Cited by 71
Campbell, N. R. C., Khan, N. A., Hill, M. D., Tremblay, G., Lebel, M., Kaczorowski, J. A., McAlister, F. A., Lewanczuk, R. Z., & Tobe, S. W. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70490-8 · Cited by 47
Nephrology: 4. Strategies for the care of adults with chronic kidney disease.
Stigant, C. E., Stevens, L., & Levin, A. (2003) · Europe PMC (PubMed Central) · Cited by 39
Use of Glycated Hemoglobin (A1C) in the Diagnosis of Type 2 Diabetes Mellitus in Adults
Goldenberg, R., CHENG, A. Y. Y., Punthakee, Z., & CLEMENT, M. A. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)53006-0 · Cited by 35
Campbell, N. R. C. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70796-1 · Cited by 19
Andersen, S., & Fried, L. P. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_27 · Cited by 3
Cited by
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
Carrero, J. J., Hecking, M., Chesnaye, N. C., & Jager, K. J. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.181 · Cited by 923
Mills, K. T., Xu, Y., Zhang, W., Bundy, J. D., Chen, C.-S., Kelly, T. N., Chen, J., & He, J. (2015) · Kidney International · doi:10.1038/ki.2015.230 · Cited by 865
Wang, L., Xu, X., Zhang, M., Hu, C., Zhang, X., Li, C., Nie, S., Huang, Z., Zhao, Z., Hou, F. F., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.6817 · Cited by 568
Metadata
- Authors
- Arora, P., Vasa, P., Brenner, D., Iglar, K., McFarlane, P., Morrison, H., & Badawi, A.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2013-05-06
- Volume
- 185
- Issue
- 9
- Pages
- E417-E423
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2074702660
- Cited by
- 346
- References
- 34
- FWCI
- 20.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.